Part 1 is available here. This post includes the Table of Contents and sections A and B (twelve pages)of the LNP Files. Sections D through G (also twelve pages) will be posted within the week. ### Table of Contents (modified for LNP files release on SubStack): A. Introduction and Overview of […]
Part 1: The Alarming LNP (Lipid Nanoparticles) History You Haven’t Been Shown – the LNP Developers’ Own Studies Dating Back 20 Years
Introduction and Executive Brief sent to lawmakers & state investigators this summer. The below work was written from March to May 2023; after working with attorneys and physicians to bring this information to the attention of our lawmakers, the below introduction and eight-page Executive Brief/synopsis accompany a 90-page executive summary […]
Report 76: Pfizer Had Data to Announce Its COVID-19 Vaccine’s Alleged “Efficacy” in October 2020. Why Did Pfizer Delay the Announcement Until November 9, 2020, Six Days After the 2020 U.S. Presidential Election?
Executive summary On July 21, 2020, the United States (U.S.) government, Pfizer, and BioNTech signed a contract, known as a Statement of Work (SOW), for the rapid development of and obtaining regulatory licensure for a COVID-19 vaccine by October 31, 2020, a few days prior to the November 3, 2020, […]
Losing Control of the Controlled Clinical Trial in These Times of Emergency Use Authorization (EUA) Vaccines
Do you remember your high school science teacher explaining what a controlled experiment is? It is when just one thing is changed in the group receiving the experimental intervention (compared to the “control” group receiving standard or no treatment), then one waits to see if there is a difference in […]
“170 Patients That Changed Everything” – Spectator | Australia
Few people realise that the Emergency Use Authorisation (EUA) of the Pfizer-BioNTech Covid-19 Vaccine/BNT162b2 was granted on the efficacy data of 170 patients. The 162 who received a placebo and 8 patients who were vaccinated formed the basis of the 95 per cent efficacy claims. There has not been much […]
Report 42: Pfizer’s EUA Granted Based on Fewer Than 0.4% of Clinical Trial Participants. FDA Ignored Disqualifying Protocol Deviations to Grant EUA.
Locations of the 170 Pfizer Clinical Trial Patients Used to Gain Emergency Use Authorization (EUA) for Its COVID mRNA Vaccine. Courtesy of OPENVAET.org For audio-visual explanations of this report, please see these videos. So much has been written about the pivotal Pfizer Trial for COVID-19 (C4591001), that it is sometimes […]